Technical Analysis for SDGR - Schrodinger, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | -3.00% | |
| Oversold Stochastic | Weakness | -3.00% | |
| Slingshot Bearish | Bearish Swing Setup | -3.55% | |
| New 52 Week Low | Weakness | -3.55% | |
| Outside Day | Range Expansion | -3.55% | |
| Oversold Stochastic | Weakness | -3.55% | |
| New 52 Week Closing Low | Bearish | 0.59% | |
| Narrow Range Bar | Range Contraction | 0.59% | |
| New 52 Week Low | Weakness | 0.59% |
| Alert | Time |
|---|---|
| Slingshot Bearish Entry | about 6 hours ago |
| Fell Below Previous Day's Low | about 6 hours ago |
| Down 2 % | about 6 hours ago |
| 60 Minute Opening Range Breakdown | about 7 hours ago |
| 10 DMA Support | about 10 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 07/31/2024
Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.
Sector: Healthcare
Industry: Health Information Services
Keywords: Drug Discovery Materials Science Simulation Software Pre Clinical Development
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Drug Discovery Materials Science Simulation Software Pre Clinical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 59.24 |
| 52 Week Low | 18.21 |
| Average Volume | 745,154 |
| 200-Day Moving Average | 26.80 |
| 50-Day Moving Average | 22.09 |
| 20-Day Moving Average | 20.43 |
| 10-Day Moving Average | 19.13 |
| Average True Range | 0.91 |
| RSI (14) | 35.90 |
| ADX | 8.4 |
| +DI | 25.14 |
| -DI | 26.67 |
| Chandelier Exit (Long, 3 ATRs) | 20.74 |
| Chandelier Exit (Short, 3 ATRs) | 20.94 |
| Upper Bollinger Bands | 23.38 |
| Lower Bollinger Band | 17.47 |
| Percent B (%b) | 0.22 |
| BandWidth | 28.94 |
| MACD Line | -1.01 |
| MACD Signal Line | -0.97 |
| MACD Histogram | -0.0364 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 19.86 | ||||
| Resistance 3 (R3) | 19.97 | 19.72 | 19.67 | ||
| Resistance 2 (R2) | 19.72 | 19.44 | 19.66 | 19.61 | |
| Resistance 1 (R1) | 19.24 | 19.27 | 19.12 | 19.13 | 19.55 |
| Pivot Point | 18.99 | 18.99 | 18.93 | 18.93 | 18.99 |
| Support 1 (S1) | 18.51 | 18.71 | 18.39 | 18.40 | 17.97 |
| Support 2 (S2) | 18.26 | 18.54 | 18.20 | 17.91 | |
| Support 3 (S3) | 17.78 | 18.26 | 17.85 | ||
| Support 4 (S4) | 17.67 |
